A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Bernard Goffe, MD
Dermatology Associates
Principal Investigator - Debra Breneman, MD
University of Cincinnati - Dermatology
Principal Investigator - Steven Kempers, MD
Associated Skin Care Specialists
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dermatology Specialists
Louisville, Kentucky, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2007
- Primary completion
- 20 Feb 2009
- Completion
- 27 Feb 2009
- Last update posted
- 14 Mar 2022
- Registered enrollment
- 113
- Registry id
- NCT00403559
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.